Takeda on Nycomed acquisition

Japan's corporate giants face many challenges due to a rising yen and growing competition from China. The FT's Michiyo Nakamoto talks to Yasuchika Hasegawa, chief executive and president of Takeda, Japan's largest pharmaceutical company, about the outlook for the domestic economy and the group's recent acquisition of Nycomed.